about
Will You Still Treat Me When I'm 64? Care of the Older Adult With HIV InfectionHepatitis C Virus Direct-Acting Antiviral Drug Interactions and Use in Renal and Hepatic ImpairmentPreexposure Prophylaxis For HIV Prevention: What We Know and What We Still Need to Know for ImplementationWhat Will It Take to Cure HIV?Retention in HIV care: what the clinician needs to knowNeurologic complications of HIV infectionNon-AIDS-defining cancersHIV diagnostic testing: evolving technology and testing strategiesReview of basic science advances in HIVCardiovascular risk and dyslipidemia management in HIV-infected patientsCirrhosis in hepatitis C virus-infected patients: a review for practitioners new to hepatitis C careAging, inflammation, and HIV infectionWhen patients cannot take pills: antiretroviral drug formulations for managing adult HIV infectionCure of hepatitis C virus infection without interferon alfa: scientific basis and current clinical evidencePrevention of perinatal HIV transmission: the Perinatal HIV Hotline perspectiveCROI 2014: Neurologic complications of HIV infectionComplications of HIV disease and antiretroviral therapyNew insights into HCV replication: potential antiviral targets.Screening for Human Papillomavirus-Associated Cervical Disease in HIV-Infected WomenChoosing Initial Antiretroviral Therapy: Current Recommendations for Initial Therapy and Newer or Investigational AgentsHIV preexposure prophylaxis: new data and potential useKidney Disease and HIV Infection.Cardiovascular Complications of HIV Infection.Management of Lipid Levels and Cardiovascular Disease in HIV-Infected Individuals: Just Give Them a Statin?CROI 2016: Advances in Antiretroviral Therapy.A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.Managing adverse effects and complications in completing treatment for hepatitis C virus infection.Vitamin D, bone, and HIV infection.Vitamin D and HIV: letting the sun shine in.Immune activation, HIV persistence, and the cure.Management of hepatitis C virus infection: the basicsImpact of new therapeutics for hepatitis C virus infection in incarcerated populations.Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patient.Sexually transmitted infections and HIV: diagnosis and treatment.Advanced liver disease: what every hepatitis C virus treater should know.Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder.Addressing alcohol use in HIV-infected persons.Safer conception interventions for HIV-affected couples: implications for resource-constrained settings.2011 update of the drug resistance mutations in HIV-1.Update of the past year: a review from IDSA 2011.
P1433
Q26800984-8B1F8D0A-E342-4DF5-9BF0-EDAF44EDBAE1Q26800987-EE564AFB-6EA9-464C-9D7D-5935A2E8AFB9Q26800989-58844D11-9F43-41A0-9E8F-4763973E0ABEQ26800992-7118EEA1-6276-42C4-86D5-AC7F2840F2DAQ26822455-A06150A0-E186-4E06-96F0-DFAAB4D598FBQ26825407-BB58FF0A-FAF6-4D90-A993-1811DAF7D0CAQ26826855-E5F45E14-2DC0-4751-B4EF-9349CF4D2FDDQ26830617-96F8E1E1-CE66-405B-B85E-151409AA5AC5Q26849742-4C343274-2735-4C06-9DFF-EE21A5E24482Q26851934-BFEB27E5-C33D-4550-ADFF-503D319C9625Q26853564-DECC6CC9-814F-4297-BE1D-9F72C7FDBF04Q26865415-B732CFC7-1350-4405-9272-E05BC5736431Q26999410-F279D2FD-34BE-4645-8D14-EBF114AEDF45Q27005882-F969D7ED-6396-44A5-9F3A-3EC1B098C3E6Q27016059-AAEE6F5F-E42C-4C97-8D6A-E432E956689DQ27021277-ABD3176B-828C-4672-AC26-88507C6F6FDCQ27023382-389E1BD0-28A9-432B-9DCD-191EB6FE735CQ27691438-C94DB874-02FD-4CE6-B0A5-FE8610F0809CQ28074550-44CC3DA8-E047-4C9B-B89B-07FD50A11CBDQ28075662-066EF19B-2227-458A-A485-1978CDDFD97AQ28258739-C5FB3BCE-F0F6-4E5C-93CA-C5E7CA377188Q30234837-BA5D4C7A-6BA6-4F9E-A381-B572A357D534Q30235920-844B1BA8-2A91-44E2-BEFA-DF68D3A4ABE4Q30249076-91953725-D2E9-4637-965F-F339D085C5D1Q30390360-DDE71C59-495F-40DA-8B98-1A18B2BD345DQ31162537-088BF8D1-9EEA-4399-821A-890D9870071FQ33404375-A25A501C-E7EB-4E84-90C0-7F6AAE373F00Q33603196-D0706319-7F56-4BAB-AE69-9EE6700C47CEQ34028199-66DA2F79-BCF2-406B-8392-C5C4167DD95EQ35041831-CCE4D29B-8477-4387-B51C-F2DC55483E81Q36949500-5860EA9A-A7D0-4492-9DFC-E3AA49DF8A14Q37419326-2630A166-EEB6-4C76-B6A9-445C8A2F4E39Q37701225-6DA8A3A1-C5A3-4081-8D6F-B6479A813E05Q37848901-CE55CC9B-5D87-4E6B-B838-699925A72781Q37938559-D6566164-8475-4F19-8822-7A89BB501591Q37966663-22ACF89D-F7F7-4027-A304-96A558A441ABQ37966664-7681D0CE-07C0-4077-9278-74CB44598404Q37966666-6EEEE367-CB05-4060-8267-280F3CFCBEA7Q37966667-B7219063-7E49-4EE7-9F00-A2CA3BCCE65DQ37980739-9A479107-09EE-4709-AFD5-F1A953BC7E38
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Topics in antiviral medicine
@ast
Topics in antiviral medicine
@en
Topics in antiviral medicine
@es
Topics in antiviral medicine
@it
Topics in antiviral medicine
@nl
type
label
Topics in antiviral medicine
@ast
Topics in antiviral medicine
@en
Topics in antiviral medicine
@es
Topics in antiviral medicine
@it
Topics in antiviral medicine
@nl
prefLabel
Topics in antiviral medicine
@ast
Topics in antiviral medicine
@en
Topics in antiviral medicine
@es
Topics in antiviral medicine
@it
Topics in antiviral medicine
@nl